In order to define the landscape and ascertain the impact of concurrent translocations and copy number gains in MYC and BCL2 and/or BCL6, FISH and copy number data from 260 DLBCL patients, from the Mayo/Iowa MER (Mayo Cohort), were analyzed. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.